Gerben M Visser

Title: Gerben M Visser: Innovator in Pharmacological Research

Introduction

Gerben M Visser is a notable inventor based in Weesp, Netherlands. He has made significant contributions to the field of pharmacology, particularly through his innovative work on phenylpiperazine derivatives. With a total of 9 patents to his name, Visser's inventions have the potential to impact the treatment of various neurological and psychological conditions.

Latest Patents

One of Visser's latest patents focuses on a novel group of phenylpiperazines. These compounds exhibit interesting pharmacological properties, including a high affinity for the dopamine D receptor and the serotonin reuptake site. This innovation aims to address conditions related to disturbances in the dopaminergic and serotonergic systems, such as anxiety disorders, depression, Parkinson's disease, and schizophrenia. The patent details a group of novel phenylpiperazine derivatives, which could lead to new therapeutic options for patients suffering from these conditions.

Career Highlights

Throughout his career, Gerben M Visser has worked with prominent companies in the pharmaceutical industry. Notable among these are Duphar International Research B.V. and Solvay Pharmaceuticals GmbH. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Visser has collaborated with several esteemed colleagues in his field, including Cornelis G Kruse and Martinus T M Tulp. These partnerships have likely enriched his research and contributed to the success of his inventions.

Conclusion

Gerben M Visser stands out as a significant figure in pharmacological research, with a focus on developing innovative treatments for mental health and neurological disorders. His contributions through patents and collaborations highlight his commitment to advancing medical science.